The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report

Desmoid tumors (DT) are nonmalignant mesenchymal neoplasms with a high recurrence rate. Tumors concentrate into the small bowel mesentery and the abdominal wall when associated with familial adenom...